Entering, focusing and promoting in the Canadian market is a smart move, but it's not what I'm most excited about.
My attention is on the data, MYDX's database, the consumers and users who will continue to add to the database(at little / no cost for MYDX), and the companies who need these data points for their growth, research, studies, product development, patient and doctor communication, consumer engagement and consumer feedback.
The deal with Black Swan, although not big in $$$ terms, is HUGE in terms of confirming/legitimizing the value of MYDX's data points.
It's all about the data. Why do you think facebook & google are the top advertising platforms in the world? They have the data which consumers freely give them each and everyday.
I'm not saying MYDX will ever be a google or facebook, but they are also collecting data at very little cost, and it will grow into a very valuable asset within the pot industry.
That's why i've bought several million shares.
MYDX is going higher.
